对增生性糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)与HGF的关系,Nishimura等〔25〕做了比较系统的研究,认为PDR 患者血清中HGF 浓度升高,并与视网膜新生血管生成的严重程度相关,而且血清中HGF 可作为视网膜血管损害及糖尿病视网膜病变出现和发展的重要指标。Shinoda 等〔26〕通过对糖尿病视网膜病变患者前房HGF 水平定量测定,认为HGF 在糖尿病视网膜病变的发展过程中起重要作用。
4 展 望
综上所述,PVR 是一个多细胞、多细胞因子参与的损伤愈合过度修复的过程,其具体的发生发展机制以及治疗方法尚在继续探索之中,而基因治疗似乎成为治疗PVR 的一种有效方法。HGF 作为一种多效性生长因子,其本身及受体在RPE 细胞、PVR 玻璃体及增生膜中均有表达,参与了PVR 的形成和发展。通过对PVR中HGF的进一步深入研究,可能对PVR的病因及治疗有所突破。
【参考文献】
1 Glaser BM,Cardin A,Biscoe B.Proliferative vitreoretinopathy the mechanism of development of vitreoretinal traction 〔J〕.Ophthalmology,1997;36 (7):97.
2 Tsanou E,Loachim E,StefaniotouM,et al.Immounohistochemical study of angiogenesis and proliferative activity in epiretinal membranes〔J〕.Int J Clin Pract,2005;59 (10):1157.
3 Alge CS,Suppman S,Priglinger SG,et al.Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells 〔J〕.Invest Ophthalmol Vis Sci,2003;44 (8):3629.
4 Liou GI,Pakalnis VA,Matragoon S,et al.HGF regulation of RPE proliferation in an IL1beta/retinal holeinduced rabbit model of PVR〔J〕.Mol Vis,2002;20(8):494501.
5 Eichler W,Friedrichs U,Thies A,et al.Modulation of matrix metalloproteinase and TIMP1 expression by cytokines in human RPE cells〔J〕. Invest Ophthalmol Vis Sci,2002;43:176773.
6 Yashinori M,Shionbu T,Akira M,et al.Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy〔J〕.Am J Ophthalmol, 2000;129(5):67880.
7 Fuke H,Saitou Y,Nakano T,et al.Matrix metalloproteinase,hepatocytegrowth factor,and tissue inhibitor of matrix metalloproteinase during human liver regeneration〔J〕.Liver Int,2006;26:3801.
8 Ioachim E,Stefaniotou M,Gorezis S,et al.Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy〔J〕.Eur J Ophthalmol,2005;15(3):38491.
9 DiazGil JJ,Escartin P,GarciaCanero R,et al.Purification of a liver DNAsynthesis promoter from plasma of partially hepatectomized rats〔J〕. Biochemistry,1986;235(1):4955.
10 Zarnegar R,Michalopoulos G.Purification and biological characterization of human hepatopoietin A,a polypeptide growth factor for hepatocytes〔J〕.Cancer Res,1989;49(12):331420.
11 Nakamura T,Nishizawa T,Hagiya M.Molecular cloning and expression of human hepatocyte growth factor〔J〕.Nature,1989;342(6248):4403.
12 Komada M,Kitamura N.The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the cmet receptor〔J〕.Oncogene,1993;8(9):238190.
13 Taniyama Y,Morishita R,Aoki M,et al.Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models:preclinical study for treatment of peripheral arterial disease〔J〕.Gene Ther,2001;8:1819.
14 He PM,He S,Garner JA,et al.Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor 〔J〕.Biol Res,1998;249:2537.
15 Beilmann M,van de Woude GF,Dienes HP,et al.Hepatocyte growth factorstimulated invasiveness of monocytes〔J〕.Blood,2000;95 (12):39649.
16 Liao HL,Wei JC.Expression of subretinal fluid hepatocyte growth factor and proliferative vitreoretinopathy〔J〕.Intern J Ophthalmol,2005;4(5):2213.
17 Lashkari K,Rabimi N,Kazlauskas A.Hepatocyte growth factor receptor in human RPE cells:implication in proliferative vitreoretinopathy〔J〕. Invest Ophthalmol Vis Sci,1999;40:14956.
18 Hollborn M,Krausse C,Iandiev I,et al.Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease〔J〕.Lab Invest,2004;84:96372.
19 Lashkari K,Hirose T,Yazdany J.Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity 〔J〕.Am J Pathol,2000;156:133744.
20 黄 玲,惠延年,徐 磊,等.增生性玻璃体视网膜病变玻璃体中肝细胞生长因子的变化〔J〕.第四军医大学学报,2002;23( 14):1300.
21 Mitamura Y,Takeuchi S,Matsuda A,et al.Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy〔J〕.Am J Ophthalmol,2000;129(5):67880.
22 Briggs MC,Grierson I,Hiscott P,et al.Active scatter factor (HGF/SF) in proliferative vitreoretinal disease〔J〕.Invest Ophthalmol Vis Sci,2000;41:3085.
23 Hinton DR,He S,Jin ML,et al.Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy〔J〕.Eye,2002;16:4228.
24 王 方,宋正宇,陶晓锋.替德肝素抑制冷冻后视网膜色素上皮细胞分泌肝细胞生长因子的研究〔J〕.中华眼科杂志,2005;41(2):1069.
25 Nishimura M,Nakanno K,Ushiyama M,et al.Increased serum concentration of human hepatocyte growth factor in proliferative diabetic retinopathy〔J〕.Clin Endocrinol Metab,1998;83:1958.
26 Shinoda K,Ishida S,Kawashima S,et al.Comparison of the levels of hepatocyte growth factor in aqueous fluid and serum with grades of retinopathy in patient with diabetes mellitus〔J〕.Br J Ophthalmol,1999;83:8347. 上一页 [1] [2] |